Advertisement
Screener

Janux Therapeutics, Inc. (JANX) Net Margin

Janux Therapeutics, Inc. (JANX) Net Margin

  • 2026-06-30: Net Margin -214.01%.
  • 2026-03-31: Net Margin -652.59%.
  • 2025-09-30: Net Margin -243.13%.
  • 2024-09-30: Net Margin -6391.57%.

Complete source-backed net margin history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-214.01%
2026-03-31-652.59%
2025-09-30-243.13%
2024-09-30-6391.57%
2024-06-30-66.98%
2024-03-31-1178.91%
2023-12-31-477.77%
2023-09-30-459.59%
2023-06-30-1656.39%
2023-03-31-852.49%
2022-12-31-564.67%
2022-09-30-920.90%
2022-06-30-714.08%
2022-03-31-843.93%
2021-12-31-830.20%
2021-09-30-928.90%
2021-06-30-1287.55%
2021-03-31-601.05%

Annual Net Margin

DateNet Margin
2025-12-31-1136.25%
2024-12-31-651.62%
2023-12-31-721.18%
2022-12-31-732.22%
2021-12-31-898.32%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93